# Tolvaptan for Patients With Acute Neurological Injuries

> **NCT02545114** · NA · TERMINATED · sponsor: **Polderman, Kees, H., MD, PhD** · enrollment: 25 (actual)

## Conditions studied

- Hyponatremia
- SIADH

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT02545114
- **Lead sponsor:** Polderman, Kees, H., MD, PhD
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Major protocol revision needed, current project terminated after enrollment of 25 patients.
- **Last updated:** 2018-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545114, "Tolvaptan for Patients With Acute Neurological Injuries". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02545114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*